RecallDepth
Class III Terminated

Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP Wilmington, DE 19850 by: Patheon Pharmaceuticals, Inc. Cincinnati OH 45237 Product of Switzerland NDC 0310-0657-58

This recall has been terminated (originally issued March 14, 2018).

Company
Astrazeneca Pharmaceuticals Lp
Recall Initiated
February 23, 2018
Posted
March 14, 2018
Recall Number
D-0585-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
18056 bottles
Firm Location
Wilmington, DE, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).

Distribution

Nationwide

Lot / Code Info

HN0406 02/2018 JH0341 03/2018 JH0342 03/2018 JH0147 03/2018 JC0391 04/2018 JK0147 04/2018 JL0184 04/2018 JC0402 05/2018

More recalls by Astrazeneca Pharmaceuticals Lp

View all recalls by this company →

Other recent Class III Drug recalls